[HTML][HTML] Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic …
I Gesmundo, G Granato, AC Fuentes-Fayos… - Cancers, 2021 - mdpi.com
Simple Summary Many studies have demonstrated that the antagonists of growth hormone-
releasing hormone (GHRH) exert inhibitory activities in a variety of experimental cancers; …
releasing hormone (GHRH) exert inhibitory activities in a variety of experimental cancers; …
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic …
I Gesmundo, G Granato, AC Fuentes-Fayos… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
[PDF][PDF] Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting …
I Gesmundo, G Granato, AC Fuentes-Fayos… - 2021 - iris.unife.it
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
[PDF][PDF] Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting …
I Gesmundo, G Granato, AC Fuentes-Fayos… - 2021 - pdfs.semanticscholar.org
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic …
I Gesmundo, G Granato, AC Fuentes-Fayos… - CANCERS, 2021 - ricerca.unich.it
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic …
I Gesmundo, G Granato, AC Fuentes-Fayos… - 2021 - helvia.uco.es
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic …
I Gesmundo, G Granato, AC Fuentes-Fayos… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Many studies have demonstrated that the antagonists of growth
hormone-releasing hormone (GHRH) exert inhibitory activities in a variety of experimental …
hormone-releasing hormone (GHRH) exert inhibitory activities in a variety of experimental …
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic …
I Gesmundo, G Granato, AC Fuentes-Fayos… - …, 2021 - search.proquest.com
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
[HTML][HTML] Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting …
I Gesmundo, G Granato, AC Fuentes-Fayos… - Cancers, 2021 - ncbi.nlm.nih.gov
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling
I Gesmundo, G Granato, AC Fuentes-Fayos… - CANCERS, 2021 - sfera.unife.it
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal
secretion and severe comorbidities. Some patients are resistant to medical therapies; …
secretion and severe comorbidities. Some patients are resistant to medical therapies; …